RSS

Genentech

The US FDA has approved Genetech’s Lucentis (ranibizumab injection) 0.3 mg prefilled syringe as a new administration method for the treatment of all forms of diabetic retinopathy (DR) in patients with diabetic macular oedema more

News

The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for Genentech’s venetoclax for the treatment of chronic lymphocytic leukaemia (CLL) more

News

Genentech’s phase III studies of ocrelizumab in people with relapsing multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS) show positive results more

News

Forbes reports that Roche-owned Biotech firm Genentech has stumped up $10 million in backing for the controversial '23andMe' company - a firm which gives people data on health risks based on their DNA. more

News

FDA has approved Avastin in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of metastatic carcinoma of the cervix. more